# Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy

> **NCT06514976** · — · RECRUITING · sponsor: **POLYSAN Scientific & Technological Pharmaceutical Company** · enrollment: 562 (estimated)

## Conditions studied

- Stroke, Acute
- Stroke, Ischemic

## Interventions

- **DRUG:** Cytoflavin

## Key facts

- **NCT ID:** NCT06514976
- **Lead sponsor:** POLYSAN Scientific & Technological Pharmaceutical Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-11-01
- **Target enrollment:** 562 (ESTIMATED)
- **Last updated:** 2025-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06514976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06514976, "Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06514976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*